CAS 1365888-06-7

2-Propenoic acid, 3-[4-[(1E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)-1-buten-1-yl]phenyl]-, (2E)-

CAS: 1365888-06-7

Formula: C₂₆H₂₀ClFN₂O₂

Purity: %

Color and Shape: Solid

Molecular weight: 446.9006

Ref: IN-DA00123J

(E)-3-(4-((E)-2-(2-Chloro-4-Fluorophenyl)-1-(1H-Indazol-5-Yl)But-1-En-1-Yl)Phenyl)Acrylic Acid

CAS: 1365888-06-7

(E)-3-(4-((E)-2-(2-Chloro-4-Fluorophenyl)-1-(1H-Indazol-5-Yl)But-1-En-1-Yl)Phenyl)Acrylic Acid

Purity: 98+%

Molecular weight: 446.9g/mol

Ref: 54-PC108766

Brilanestrant

CAS: 1365888-06-7

Brilanestrant

Purity: ≥98%

Molecular weight: 446.9g/mol

Ref: 54-BUP08565

Brilanestrant

CAS: 1365888-06-7

Formula: C₂₆H₂₀ClFN₂O₂

Molecular weight: 446.91

Ref: 4Z-B-170001

Brilanestrant

CAS: 1365888-06-7

Brilanestrant (GDC-0810) is a selective estrogen receptor degrader (IC50: 0.7 nM).

Formula: C₂₆H₂₀ClFN₂O₂

Purity: 99.07% - 99.17%

Color and Shape: Solid Powder

Molecular weight: 446.9

Ref: TM-T5118

GDC 0810

CAS: 1365888-06-7

Estrogen receptor degrader; therapeutic use in breast cancer

Formula: C₂₆H₂₀ClFN₂O₂

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 446.9 g/mol

Ref: 3D-FG137678